Juliana Ferreira de Souza

ORCID: 0000-0002-8538-2313
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurofibromatosis and Schwannoma Cases
  • Vascular Malformations Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Meningioma and schwannoma management
  • Neuroendocrine Tumor Research Advances
  • Soft tissue tumors and treatment
  • Public Health in Brazil
  • Pancreatic and Hepatic Oncology Research
  • Spinal Hematomas and Complications
  • Nutrition and Health in Aging
  • Metabolism, Diabetes, and Cancer
  • Women's cancer prevention and management
  • Respiratory viral infections research
  • Ophthalmology and Eye Disorders
  • Influenza Virus Research Studies
  • Facial Nerve Paralysis Treatment and Research
  • Glaucoma and retinal disorders
  • Healthcare Regulation
  • Thyroid and Parathyroid Surgery
  • Animal Disease Management and Epidemiology
  • Neurosurgical Procedures and Complications
  • Takotsubo Cardiomyopathy and Associated Phenomena

Universidade Federal de Minas Gerais
2009-2020

Pontifícia Universidade Católica de Goiás
2018

Hospital das Clínicas da Universidade Federal de Minas Gerais
2016

Faculdade de Ciências Médicas da Santa Casa de São Paulo
2012

Neurofibromatoses (NF) are a group of genetic multiple tumor growing predisposition diseases: neurofibromatosis type 1 (NF1), 2 (NF2) and schwannomatosis (SCH), which have in common the neural origin tumors cutaneous signs. They affect nearly 80 thousand Brazilians. In recent years, increased scientific knowledge on NF has allowed better clinical management reduced complication morbidity, resulting higher quality life for patients. most cases, neurology, psychiatry, dermatology, geneticists,...

10.1590/0004-282x20130241 article EN cc-by-nc Arquivos de Neuro-Psiquiatria 2014-03-01

OBJETIVO: Determinar a prevalência das características clínicas da neurofibromatose tipo 1 (NF1), avaliar sua gravidade e visibilidade quantificar baixa estatura, macrocrania, força muscular as alterações motricidade oral voz nesta enfermidade. MÉTODOS: 183 pacientes atendidos no Centro de Referência em Neurofibromatose Minas Gerais (CRNF-MG) foram avaliados quanto à frequência manifestações complicações NF1. A avaliadas com o uso escalas Riccardi Ablon respectivamente. As verificadas do...

10.1590/s0104-42302009000400012 article PT cc-by Revista da Associação Médica Brasileira 2009-01-01

Studies indicate a lower occurrence of diabetes mellitus (DM) in patients with neurofibromatosis type 1 (NF1). Fasting blood glucose (FBG) level is the main criterion used to diagnose DM and intolerance. Therefore, this study compared FBG between adults NF1 non-NF1 controls. We selected clinical records 57 out 701 individuals attending Neurofibromatosis Outpatient Reference Center Clinics Hospital Federal University Minas Gerais Brazil. The were matched controls from Brazilian Longitudinal...

10.1530/ec-15-0102 article EN cc-by-nc-nd Endocrine Connections 2015-12-03

Part 1 of this guideline addressed the differential diagnosis neurofibromatoses (NF): neurofibromatosis type (NF1), 2 (NF2) and schwannomatosis (SCH). NF shares some features such as genetic origin neural tumors cutaneous manifestations, affects nearly 80 thousand Brazilians. Increasing scientific knowledge on has allowed better clinical management reduced rate complications morbidity, resulting in higher quality life for patients. Most medical doctors are able to perform diagnosis, but wide...

10.1590/0004-282x20150042 article EN cc-by-nc Arquivos de Neuro-Psiquiatria 2015-06-01

Abstract Background The 2009 pandemic influenza A (H1N1) virus spread rapidly throughout B razil. Non‐adjuvanted and the adjuvanted H1N1/09 monovalent vaccine were recommended as a single dose to persons at risk including renal transplant recipients ( RTR ). We analyzed safety immune response of 2 vaccines in , identified factors influencing response. Methods total 78 received either H1N1 AS 03‐adjuvanted or non‐adjuvanted vaccine, 58 healthy controls vaccine. Antibody responses measured by...

10.1111/j.1399-3062.2012.00769.x article EN Transplant Infectious Disease 2012-08-13

BACKGROUND Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disease characterized by multisystem involvement including low bone mineral density (BMD). OBJECTIVE To assess the phenotype of individuals with NF1 and verify its association nutrient intake. METHODS Twenty-six adults underwent assessments using dual-energy X-ray absorptiometry (DXA) food intake evaluations. They were compared to 26 unaffected matched control patients. Weight, height, waist circumference (WC)...

10.1590/1806-9282.66.5.666 article EN Revista da Associação Médica Brasileira 2020-05-01

Neurofibromatosis type 1 (NF1) causes neural and cutaneous disorders reduced exercise capacity. Exercise/heat exposure increasing internal temperature must be compensated by eccrine sweat function warmed skin vasodilation. We suspected NF1 could adversely affect and/or vascular thermoregulatory responses (VTR).The VTR of 25 volunteers (14 males, 11 females; 16-57 years old) were compared with 23 non-NF1 controls matched sex, age, height weight (CG). Sweating was induced 1) pilocarpine 1%...

10.1590/0004-282x20160122 article EN cc-by-nc Arquivos de Neuro-Psiquiatria 2016-10-01

Objective: To evaluate the consonance betweenthe Goldman and pneumática planation to nometers under effect of water drink test. Methods: Cross-sectional descriptive study consisting a sample 102 eyes from private hospital in Goiânia (GO) 2013 2015,with na evaluation different intraocular pressures (IOP) pneumatic flattening when submitted TSH. Results: The average age was 52.17 (± 15.21) years old, 60.8% patients were female 39.2% [...]

10.5935/0034-7280.20180003 article EN cc-by Revista Brasileira de Oftalmologia 2018-01-01

A Síndrome de Ramsay Hunt ocorre pela reativação do vírus varicela zoster latente no gânglio geniculado nervo facial, sendo caracterizada por paralisia facial periférica e lesões vesiculares em pavilhão auricular. O diagnóstico é essencialmente clinico, baseado na história exame físico paciente. tratamento com antiviral corticoide, forma precoce, tem demonstrado bom prognóstico.

10.34119/bjhrv4n3-280 article PT Brazilian Journal of Health Review 2021-06-17
Coming Soon ...